Association between Three Therapeutic Strategies and Clinical Outcomes of 2009 FIGO Stage IB2/IIA2 Cervical Cancer

Table 4

Multivariate survival analysis.

	OS			PFS
	HR	95%CI		HR	95%CI
Age (years)	0.759	0.808–5.646	0.126	0.509	0.710–3.900	0.241
Pretreatment hemoglobin	−0.002	0.404–2.464	0.997	0.284	0.282–1.713	0.500
Differentiation degree	−0.708	0.186–1.307	0.155	−0.363	0.405–3.373	0.429
Histology type	−0.107	0.295–2.735	0.851	0.156	0.327–2.050	0.773
FIGO stage	−0.203	0.297–2.245	0.694	−0.200	0.126–1.451	0.669
Tumor size	−0.574	0.142–2.236	0.415	−0.849	0.180–2.076	0.173
Lymph node metastasis	−0.081	0.320–2.657	0.881	0.010	0.387–2.634	0.984
Vascular tumor thrombus	−0.506	0.182–1.998	0.408	−0.289	0.240–2.341	0.619
Vaginal margin	−1.220	0.030–2.879	0.294	−0.477	0.069–5.594	0.671
Deep stromal invasion	−0.664	0.163–1.623	0.257	−0.514	0.227–1.575	0.298
Adjuvant treatment	−0.048	0.327–2.778	0.929	−0.287	0.311–1.813	0.524
Therapeutic strategies
PST	Reference
NAC + RS	1.28	0.53–3.088	0.583	1.559	0.716–3.394	0.264
CCRT	1.192	0.476–2.988	0.708	1.012	0.413–2.482	0.979